Gurkamal Chatta

Roswell Park Comprehensive Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma”.

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

New England Journal of Medicine(2024)10.1056/nejmoa2401726

N/A

3.9DataRank · unranked

151 citations

Karla V. Ballman, Guru Sonpavde, Stephanie Berg, William Y. Kim, Rahul Atul Parikh +35 more

Phase II Trial of Concurrent Nivolumab and Radiation Therapy for Muscle-Invasive Bladder Cancer of Older or Chemotherapy-Ineligible Patients

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.11.024

N/A

0.405DataRank · unranked

7 citations

Lance K. Heilbrun, Nitin Vaishampayan, Felicity W. K. Harper, Dongping Shi, Daryn Smith +10 more

Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer

Cancer Chemotherapy and Pharmacology(2025)10.1007/s00280-025-04840-2

N/A

0.241DataRank · unranked

4 citations

Anmbreen Jamroze, Dharmesh Gopalakrishnan, Rohit Jain, Changchuan Jiang, Julianne L. Holleran +11 more

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors

Nature Communications(2021)10.1038/s41467-021-21619-0

N/A

0DataRank · unranked

188 citations

Toshifumi Hoki, Takaaki Oba, Vaibhav Jain, Hongbin Chen, Kristopher Attwood +11 more

Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance

Cancer Letters(2021)10.1016/j.canlet.2021.06.006

N/A

0DataRank · unranked

135 citations

Gurkamal Chatta, Dean G. Tang, Anmbreen Jamroze

NFκB-Activated COX2/PGE2/EP4 Axis Controls the Magnitude and Selectivity of BCG-Induced Inflammation in Human Bladder Cancer Tissues

Cancers(2021)10.3390/cancers13061323

N/A

0DataRank · unranked

33 citations

Per Basse, Weijian Jiang, Khurshid A. Guru, Gurkamal Chatta, Paweł Kaliński +1 more

Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness

Essays in Biochemistry(2022)10.1042/ebc20220003

N/A

0DataRank · unranked

23 citations

Wen Li, Igor Puzanov, David W. Goodrich, Gurkamal Chatta, Dean G. Tang +1 more

A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0613

N/A

0DataRank · unranked

9 citations

Qiang Cao, Li Wang, Jianmin Wang, Bo Xu, Kristopher Attwood +10 more

Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promises

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.25.568612

N/A

0DataRank · unranked

1 citations

Yunfei Wang, Xiaozhuo Liu, Shan Wu, Moyi Wang, Steven G. Turowski +9 more

Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises

International Journal of Molecular Sciences(2024)10.3390/ijms25042123

N/A

0DataRank · unranked

31 citations

Yunfei Wang, Xiaozhuo Liu, Shan Wu, Moyi Wang, Steven G. Turowski +9 more

A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1728

N/A

0DataRank · unranked

7 citations

Gurkamal Chatta, Rohit K. Jain, Helen Moon, Scott E. Delacroix, Alana Fang +10 more

Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells

Cell stem cell(2024)10.1016/j.stem.2024.05.008

N/A

0DataRank · unranked

20 citations

Jie Wang, Mark D. Long, Spencer R. Rosario, Amanda Tracz, Yibing Ji +16 more

High intratumoral CD8+ T‐cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy

The Prostate(2020)10.1002/pros.24068

N/A

0DataRank · unranked

85 citations

Kristopher Attwood, Wiam Bshara, James L. Mohler, Khurshid A. Guru, Bo Xu +3 more

Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate Cancer

medRxiv(2025)10.1101/2025.04.22.25326208

N/A

0DataRank · unranked

1 citations

Anmbreen Jamroze, Dharmesh Gopalakrishnan, Rohit Jain, Changchuan Jiang, Julianne L. Holleran +10 more

A circulating T-cell differentiation marker to predict response to immune checkpoint inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.13.095844

N/A

0DataRank · unranked

3 citations

Toshifumi Hoki, Takaaki Oba, Vaibhav Jain, Hongbin Chen, Kristopher Attwood +11 more

A phase Ib trial of enzalutamide with venetoclax in metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps5599

N/A

0DataRank · unranked

2 citations

Jason Kirk, John W. Davis, Saby George, Ellis Levine, Jan H. Beumer +4 more